Hyperlactataemia induced by CVVHDF with low lactate bicarbonate-buffered solutions in patients with liver dysfunction

Nephrology Dialysis Transplantation

Volumn 21, Issue 4, 2006, Pages 1096-1099

  Ho, Kwok M ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Acute renal failure; Dialysis lactate acidosis

Indexed keywords

BICARBONATE; DIALYSIS FLUID; LACTIC ACID; NORADRENALIN; WARFARIN;

ADULT; ANAMNESIS; ANTICOAGULANT THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CLINICAL FEATURE; CONTINUOUS HEMODIAFILTRATION; DIALYSATE; EMBOLISM; FEMALE; GENERAL CONDITION DETERIORATION; HEART ATRIUM FIBRILLATION; HEMODYNAMICS; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERLACTATEMIA; INTESTINE ISCHEMIA; KIDNEY FAILURE; LAPAROTOMY; LIVER DYSFUNCTION; LIVER FUNCTION; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RESPIRATORY FAILURE; RISK ASSESSMENT; SEPTIC SHOCK; VALVULAR HEART DISEASE;

ACIDOSIS, LACTIC; BICARBONATES; FEMALE; HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, ACUTE; LACTATES; LIVER FAILURE; MALE; MIDDLE AGED;

EID: 33645314903     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi339     Document Type: Article

References (11)

1. Benjamin E. Continuous venovenous hemofiltration with dialysis and lactate clearance in critically ill patients. Crit Care Med 1997; 25: 4-5
2. McLean AG, Davenport A, Cox D, Sweny P. Effects of lactate-buffered and lactate-free dialysate in CAVDH patients with and without liver dysfunction. Kidney Int 2000; 58: 1765-1772
3. Zimmerman D, Cotman P, Ting R, Karanicolas S, Tobe SW. Continuous veno-venous haemodialysis with a novel bicarbonate dialysis solution: prospective cross-over comparison with a lactate buffered solution. Nephrol Dial Transplant 1999; 14: 2387-2391
4. Kierdorf HP, Leue C, Arns S. Lactate- or bicarbonate-buffered solutions in continuous extracorporeal renal replacement therapies. Kidney Int 1999; 72 [Suppl]: S32-S36
5. Schetz M, Leblanc M, Murray PT. The Acute Dialysis Quality Initiative-part VII: Fluid composition and management in CRRT. Adv Ren Replace Ther 2002; 9: 282-289
6. Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem HH, Wood EM. The Warfarin Reversal Consensus Group. Warfarin reversal: Consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. MJA 2004; 181: 492-497
7. De Backer D. Lactic acidosis. Minerva Anestesiol 2003; 69: 281-284
8. Levraut J, Ciebiera JP, Jambou P, Ichai C, Labib Y, Grimaud D. Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients. Crit Care Med 1997; 25: 58-62
9. Cointault O, Kamar N, Bories P et al. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions. Nephrol Dial Transplant 2004; 19: 171-178
10. Bunchman TE, Maxvold NJ, Brophy PD. Pediatric convective hemofiltration: normocarb replacement fluid and citrate anticoagulation. Am J Kidney Dis 2003; 42: 1248-1252
11. Clemmesen O, Ott P, Larsen FS. Splanchnic metabolism in acute liver failure and sepsis. Curr Opin Crit Care 2004; 10: 152-155